Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging Nano-/Biotechnology Drives Oncolytic Virus-Activated and Combined Cancer Immunotherapy
Chao Fang, Gaozhe Xiao, Taixia Wang, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
Mohammad Chehelgerdi, Matin Chehelgerdi, Milad Khorramian‐Ghahfarokhi, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 72
A Distinctive Insight into Inorganic Sonosensitizers: Design Principles and Application Domains
Wen Qin, Qiaoling Yang, Chunyan Zhu, et al.
Small (2024) Vol. 20, Iss. 25
Closed Access | Times Cited: 29
Photodynamic therapy for cancer: mechanisms, photosensitizers, nanocarriers, and clinical studies
Wanchen Zhao, Liqing Wang, Meihong Zhang, et al.
MedComm (2024) Vol. 5, Iss. 7
Open Access | Times Cited: 25
Oncolytic Virotherapy: A New Paradigm in Cancer Immunotherapy
Simona Ruxandra Volovăț, Dragoş Viorel Scripcariu, Ingrid-Andrada Vasilache, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1180-1180
Open Access | Times Cited: 22
Wrecking neutrophil extracellular traps and antagonizing cancer-associated neurotransmitters by interpenetrating network hydrogels prevent postsurgical cancer relapse and metastases
Hang Zhou, Chunyan Zhu, Qing Zhao, et al.
Bioactive Materials (2024) Vol. 39, pp. 14-24
Open Access | Times Cited: 21
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
Man Wang, Fei Yu, Yuan Zhang
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 8
Multichannel Sonocatalysis Amplifiers Target IDH1‐Mutated Tumor Plasticity and Attenuate Ros Tolerance to Repress Malignant Cholangiocarcinoma
Duo Wang, Xiaoqi Zhu, Xiaobo Wang, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 48
Closed Access | Times Cited: 24
Targeting Vascular Destruction by Sonosensitizer‐Free Sonocatalytic Nanomissiles Instigates Thrombus Aggregation and Nutrition Deprivation to Starve Pancreatic Cancer
Yazhi He, Taixia Wang, Yi-Ran Song, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 30
Closed Access | Times Cited: 14
Truncated PD1 Engineered Gas‐Producing Extracellular Vesicles for Ultrasound Imaging and Subsequent Degradation of PDL1 in Tumor Cells
Siyan Zhang, Yuan Liang, Panpan Ji, et al.
Advanced Science (2024) Vol. 11, Iss. 12
Open Access | Times Cited: 9
Anti-tumor immune potentiation targets-engineered nanobiotechnologies: Design principles and applications
Rong Jiao, Xia Lin, Qian Zhang, et al.
Progress in Materials Science (2023) Vol. 142, pp. 101230-101230
Closed Access | Times Cited: 20
Nanomedicine‐encouraged cellular autophagy promoters favor liver fibrosis progression reversal
Cheng Qian, Yan Zhang, Xiaoyang Chen, et al.
View (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 8
Expression and Clinical Significance of NUDCD1, PI3K/AKT/mTOR Signaling Pathway-Related Molecules and Immune Infiltration in Breast Cancer
Wei Wen, Yuehua Li, Xi Cao, et al.
Clinical Breast Cancer (2024) Vol. 24, Iss. 6, pp. e429-e451
Open Access | Times Cited: 4
Efficiency of bladder-sparing strategies for bladder cancer: an umbrella review
Deng-xiong Li, Qing-xin Yu, Ruicheng Wu, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 4
Engineered Cancer Nanovaccines: A New Frontier in Cancer Therapy
Yijie Wang, Congrui Liu, Chao Fang, et al.
Nano-Micro Letters (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 4
Interactions Between Radiotherapy Resistance Mechanisms and the Tumor Microenvironment
Dengxiong Li, Jie Wang, Xinrui Li, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104705-104705
Closed Access
Development and Characterization of Novel FAP-Targeted Theranostic Pairs: A Bench-to-Bedside Study
Wei Huang, Yizhen Pang, Qiufang Liu, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 10
Immunogenic cell death-based oncolytic virus therapy: a sharp sword of tumor immunotherapy
Jingyu Zhang, Jiahe Chen, Kezhi Lin
European Journal of Pharmacology (2024) Vol. 981, pp. 176913-176913
Open Access | Times Cited: 3
Nanomaterials-driven in situ vaccination: a novel frontier in tumor immunotherapy
Naimeng Liu, Xiangyu Wang, Zhongzhao Wang, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Breaking Barriers in Oncology: Harnessing Sonodynamic Therapy for Enhanced Tumor Metabolism Regulation
Yangmengfan Chen, Kun Li, Hao Du, et al.
Small (2025)
Closed Access
Oncolytic Adenovirus Armoring with CXCL9 and IL15 Shows Potent Antitumor Activity and Boosts CAR-T Therapy for Prostate Cancer
Lin Fang, Xueyan Wang, Yi Zhang, et al.
Human Gene Therapy (2025)
Closed Access
Cancer Immunotherapy
Javad Arabpour, Fatemeh Davodabadi, Manisha Nigam
(2025), pp. 49-113
Closed Access
Strategies for small extracellular vesicle-based cancer immunotherapy
Yundi Chen, Shasha Tang, Fengfeng Cai, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 3
Relationship between clonal evolution and drug resistance in bladder cancer: A genomic research review
Zhouting Tuo, Ying Zhang, Dengxiong Li, et al.
Pharmacological Research (2024) Vol. 206, pp. 107302-107302
Open Access | Times Cited: 3
Genetically Engineered Bacteria as A Living Bioreactor for Monitoring and Elevating Hypoxia‐Activated Prodrug Tumor Therapy
Hongwei Zhang, Linfu Chen, Qian Chen, et al.
Advanced Healthcare Materials (2024) Vol. 14, Iss. 1
Closed Access | Times Cited: 3
Glucosylation endows nanoparticles with TLR4 agonist capability to trigger macrophage polarization and augment antitumor immunity
Li Liu, Shengxiang Fu, Wencheng Zhu, et al.
Biomaterials (2023) Vol. 304, pp. 122424-122424
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top